SCHEMBL20174242

SCHEMBL20174242

c1ccc(-c2ccc(-c3cc(-c4ccccc4-c4cccc5c4-c4ccccc4C54c5ccccc5-c5oc6ccccc6c54)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.34
MEN1 O00255 6/20 0.34
MAPT P10636 6/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 5/20 0.34
NTSR1 P30989 1/20 0.34
KDM4E B2RXH2 3/20 0.34
LMNA P02545 2/20 0.34
GLA P06280 1/20 0.34
MAOB P27338 2/20 0.32
MAOA P21397 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
BRD4 O60885 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
CYP2C19 P33261 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174258 0.96 KMT2A (0.36) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174290 0.95 KDM4E (0.31) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174241 0.94 KMT2A (0.36) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174227 0.93 KMT2A (0.36) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174266 0.92 CYP1A1 (0.35) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL22326526 0.92 CYP1A1 (0.35) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174265 0.92 CYP1A1 (0.35) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174717 0.91 MEN1 (0.36) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174248 0.89 KMT2A (0.35) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL20174230 0.88 ALDH1A1 (0.38) KMT2AMEN1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG KMT2A 1480/4885MEN1 611/4885MAPT 811/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG KMT2A 1480/4885MEN1 611/4885MAPT 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.